-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Vor Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Vor Biopharma Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.2M, a 45.5% decline year-over-year.
- Vor Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $6.71M, a 26.3% increase year-over-year.
- Vor Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was $8.17M, a 517% increase from 2022.
- Vor Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was $1.32M, a 1013% increase from 2021.
- Vor Biopharma Inc. annual Nonoperating Income (Expense) for 2021 was $119K, a 310% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)